$Lexaria Bioscience(LEXX.US)$Reuters· 3 mins ago Lexaria Bioscience: Human Pilot Study #2, GLP-1-H24-2 Underway & First Dosing Visit for All Nine Study Participants Has Already Concluded
$Lexaria Bioscience(LEXX.US)$ Company AnnouncementsLexaria Bioscience Showcases Drug Delivery Breakthrough Lexaria Bioscience Corp. (LEXX) has released an update. Lexaria Bioscience Corp., a leader in drug delivery platforms, will present its latest advancements in improving GLP-1 drugs using its DehydraTECH technology at the 14th Annual LD Micro Invitational in New York. CEO Chris Bunka is set to discuss recent discoveries and forthcoming studies that could significantly impact...
$Lexaria Bioscience(LEXX.US)$glp is like AI.. everyone's chasing the problem with bioscience biotech to go from phase one phase two phase 3 human trials final most companies never make it that far it's a series of disappointments by the time it ever gets approved Lily will be a 2 trillion dollar company
Trytosaveabit楼主RiqueG:
To very positive PR in last 30 days and price craters? I don’t see any reason for it. At least not published reason yet? May be a buy opportunity? GL
Lexaria Bioscience股票讨论区
Lexaria Bioscience: Human Pilot Study #2, GLP-1-H24-2 Underway & First Dosing Visit for All Nine Study Participants Has Already Concluded
NEWS
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs
Company AnnouncementsLexaria Bioscience Showcases Drug Delivery Breakthrough
Lexaria Bioscience Corp. (LEXX) has released an update. Lexaria Bioscience Corp., a leader in drug delivery platforms, will present its latest advancements in improving GLP-1 drugs using its DehydraTECH technology at the 14th Annual LD Micro Invitational in New York. CEO Chris Bunka is set to discuss recent discoveries and forthcoming studies that could significantly impact...
Benzinga· 4 mins ago
暂无评论